Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Furst

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Blood Advances|April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphomaChiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
BMC Cancer|November 25, 2020
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patientsLuca Castagna, Alessandro Busca, Stefania Bramanti, et al.
Acta Oncologica (Stockholm, Sweden)|October 10, 2022
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA studyBaptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, et al.
Current Research in Translational Medicine|October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
British Journal of Haematology|October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT studyFrédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.
Blood Advances|April 1, 2020
Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphomaChiara De Philippis, Faezeh Legrand-Izadifar, Stefania Bramanti, et al.
BMC Cancer|November 25, 2020
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patientsLuca Castagna, Alessandro Busca, Stefania Bramanti, et al.
Acta Oncologica (Stockholm, Sweden)|October 10, 2022
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA studyBaptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, et al.
Current Research in Translational Medicine|October 26, 2024
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Nicola Polverelli, Joe Tuffnell, et al.
British Journal of Haematology|October 3, 2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT studyFrédéric Baron, Arnon Nagler, Jacques-Emmanuel Galimard, et al.
Blood Advances|August 20, 2020
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-CyJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Bone Marrow Transplantation|September 3, 2022
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamideJacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, et al.
Pageof 5